NEW YORK (MarketWatch)
Pfizer Inc. said its third-quarter profit fell to $2.59 billion, or 39 cents a share, from $3.21 billion, or 43 cents a share, in the year-ago period
The pharmaceutical company said adjusted per-share earnings rose 16% to 58 cents from 50 cents
Reported revenue edged down 2% to $12.64 billion from $12.95 billion a year earlier
Analysts polled by FactSet expected earnings of 56 cents per share on revenue of $12.7 billion
Pfizer cut its 2013 per-share earnings guidance to a range of $3.05 to $3.15 from $3.07 to $3.22 previously
Pfizer Inc. said its third-quarter profit fell to $2.59 billion, or 39 cents a share, from $3.21 billion, or 43 cents a share, in the year-ago period
The pharmaceutical company said adjusted per-share earnings rose 16% to 58 cents from 50 cents
Reported revenue edged down 2% to $12.64 billion from $12.95 billion a year earlier
Analysts polled by FactSet expected earnings of 56 cents per share on revenue of $12.7 billion
Pfizer cut its 2013 per-share earnings guidance to a range of $3.05 to $3.15 from $3.07 to $3.22 previously
No hay comentarios:
Publicar un comentario